Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2009 1
2010 1
2011 2
2012 2
2013 4
2014 4
2015 3
2016 8
2017 6
2018 5
2019 10
2020 14
2021 17
2022 16
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
Darie AM, Khanna N, Jahn K, Osthoff M, Bassetti S, Osthoff M, Schumann DM, Albrich WC, Hirsch H, Brutsche M, Grize L, Tamm M, Stolz D. Darie AM, et al. Among authors: osthoff m. Lancet Respir Med. 2022 Sep;10(9):877-887. doi: 10.1016/S2213-2600(22)00086-8. Epub 2022 May 23. Lancet Respir Med. 2022. PMID: 35617987 Clinical Trial.
Isavuconazol.
Osthoff M, Bättig V, Khanna N. Osthoff M, et al. Ther Umsch. 2016;73(8):475-481. doi: 10.1024/0040-5930/a000821. Ther Umsch. 2016. PMID: 27731785 Review. German. No abstract available.
Relative bradycardia in patients with COVID-19.
Capoferri G, Osthoff M, Egli A, Stoeckle M, Bassetti S. Capoferri G, et al. Among authors: osthoff m. Clin Microbiol Infect. 2021 Feb;27(2):295-296. doi: 10.1016/j.cmi.2020.08.013. Epub 2020 Aug 18. Clin Microbiol Infect. 2021. PMID: 32822885 Free PMC article. No abstract available.
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler P, Leimbacher M, Charitos P, Moser S, Heijnen IAFM, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci MR, Huber LC, Stüssi-Helbling M, Albrich WC, Sendi P, Osthoff M. Urwyler P, et al. Among authors: osthoff m. Front Immunol. 2023 Oct 27;14:1255292. doi: 10.3389/fimmu.2023.1255292. eCollection 2023. Front Immunol. 2023. PMID: 37965347 Free PMC article. Clinical Trial.
Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020.
Dräger S, von Rotz M, Labhardt ND, Siegemund M, Rentsch KM, Osthoff M, Franzeck FC. Dräger S, et al. Among authors: osthoff m. Open Forum Infect Dis. 2023 Mar 20;10(4):ofad143. doi: 10.1093/ofid/ofad143. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37077503 Free PMC article.
96 results